Emami Limited has informed the Exchange about Re-appointment of Shri H. V. Agarwal, subject to approval of shareholders at the ensuing AGM.
EMAMILTD · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Emami Limited's Board approved the audited financial results for Q4 and FY ended March 2026. Consolidated revenue from operations stood at Rs 92,510 Lacs for Q4 and Rs 3,77,951 Lacs for the full year, compared to Rs 3,80,919 Lacs in the prior year — a marginal decline. Profit after tax (PAT) was Rs 14,317 Lacs for Q4 and Rs 77,526 Lacs for FY26 vs Rs 80,274 Lacs in FY25. The Board also re-appointed Shri Harsha Vardhan Agarwal (DIN: 00150089) as Vice-Chairman & Managing Director for a further 5 years after his current term ends on 31st March 2027, subject to shareholder approval at the 43rd AGM on 25th August 2026. Additionally, the company re-appointed M/s. V. K. Jain & Co as Cost Auditors for FY27 and announced two post-year acquisitions — 73.5% stake in associate Axiom Ayurveda (up to Rs 200 Cr) and 60% stake in IncNut Digital (up to Rs 321 Cr). Auditors issued an unmodified opinion.
Revenue and profit declined year-on-year, but the MD re-appointment provides leadership continuity. Post-year acquisitions signal expansion into digital and Ayurvedic segments. Shareholders will vote on the MD's reappointment at the August AGM.